IRCT20200516047461N1CompletedPhase 2
Evaluating the effects of Warfarin on permacath function in hemodialysis patients
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 86
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to no limit (—)
- Sex
- All
Inclusion Criteria
- •Patients who were a candidate for the second time embedding of permanent arteriovenous catheters
- •Informed consent to participate in the study
- •Age above 18 years old
Exclusion Criteria
- •History of major hemorrhages (requiring blood transfusion, retroperitoneal or intracranial hemorrhage, inducing hypovolemia, leading to more than two units decrease in hemoglobin) within the previous three months
- •Progressive diabetic retinopathy
- •Less than 12 months of life-expectancy because of systemic disease or malignancies
- •Poorly controlled hypertension (systolic blood pressure>200 mmHg or diastolic blood pressure>100 mmHg measured three times within two weeks)
- •Absolute platelet count less than 100000
- •International normalized ratio (INR)=1.3
- •Partial thrombin time (PTT)= 5 folds than the normal range
- •Hypersensitivity to Warfarin
- •Active peptic ulcer
- •Pregnancy or lactation
- •Documented aortic aneurysm
Investigators
Similar Trials
Recruiting
Phase 4
Outcomes of Warfarin and Rivaroxaban (Xalerban) consumption in patients with Atrial fibrillatioIRCT20170530034232N2Vice-Chancellor For Research and Technology of Guilan University of Medical Sciences330
Recruiting
Phase 2
Effect of warfarin and rivaroxaban in coronary endartherectomyIRCT20181124041746N1Kermanshah University of Medical Sciences120
Withdrawn
Phase 4
A Prospective Study on Warfarin Management Post Heart Valve Replacement or Heart Valve Repair SurgeryPost Mechanical Heart Valve SurgeryWarfarin Management in post mechanical heart valve surgery patients.Cardiovascular - Other cardiovascular diseasesSurgery - Other surgeryACTRN12613000818730Flinders Medical Centre140
Not yet recruiting
Not Applicable
Comparison of Efficacy and Safety between Warfarin, Rivaroxaban and Edoxaban in patients with acute pulmonary embolism in showa universityJPRN-UMIN000020069Division of Cardiology, Department of Medicine,Showa university100
Active, not recruiting
Not Applicable
Interaction médicamenteuse entre la warfarine (Coumadine®) et l’association amoxicilline-acide clavulanique (Augmentin®)maladies thromboemboliquesMedDRA version: 8.1Level: PTClassification code 10043607Term: thromboseEUCTR2006-003432-30-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)